← All indications
Carcinoma, Bronchogenic
Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.
Subtype terms (2)
More specific conditions that are subtypes of Carcinoma, Bronchogenic in the MeSH hierarchy.
- Carcinoma, Non-Small-Cell Lung
1746 drugs (347 approved, 1399 experimental)
- Small Cell Lung Carcinoma
535 drugs (165 approved, 370 experimental)
Drugs by status
Approved for this indication (1)
Phase 3 trials (9)
Phase 2 trials (10)
Phase 1 trials (3)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (2)